| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | T M Marteau | |
| R T Croyle | |||
| P2860 | cites work | The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing | Q44363828 |
| Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners | Q45293786 | ||
| Testing for Huntington's disease with support for all parties | Q45293838 | ||
| Uptake of presymptomatic predictive testing for Huntington's disease | Q45296107 | ||
| Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender. | Q50974548 | ||
| Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. | Q51108076 | ||
| Psychological responses to BRCA1 mutation testing: preliminary findings. | Q51108082 | ||
| DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. | Q51140072 | ||
| Attributions for disability: The influence of genetic screening | Q57745696 | ||
| Perceived risk not actual risk predicts uptake of amniocentesis | Q70143339 | ||
| BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes | Q71122393 | ||
| Completeness of reporting trial results: effect on physicians' willingness to prescribe | Q72676670 | ||
| Presentation of screen negative results on serum screening for Down's syndrome: variations across Britain | Q73452125 | ||
| "Talking About Chance": The Presentation of Risk Information During Genetic Counseling for Breast and Ovarian Cancer | Q85527780 | ||
| Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making | Q33677759 | ||
| Uptake of genetic testing for cancer predisposition. | Q33679403 | ||
| Objective standards are not enough: affective, self-evaluative, and behavioral responses to social comparison information | Q34422133 | ||
| Screening for carriers of cystic fibrosis through primary health care services | Q35180656 | ||
| Uptake of cystic fibrosis testing in primary care: supply push or demand pull? | Q35188406 | ||
| Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. | Q35889480 | ||
| Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration | Q36887008 | ||
| On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program | Q39492418 | ||
| A guide to constructs of control | Q41130958 | ||
| The new genetics in clinical practice | Q41728150 | ||
| Screening for Down's syndrome | Q43380168 | ||
| Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families | Q44312343 | ||
| P433 | issue | 7132 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | medical genetics | Q1071953 |
| P304 | page(s) | 693-696 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | The new genetics. Psychological responses to genetic testing | |
| P478 | volume | 316 |
| Q35136009 | "Am I carrier?" The patient's lived experience of thrombophilia genetic screening and its outcome |
| Q39760448 | A population-based survey in Australia of men's and women's perceptions of genetic risk and predictive genetic testing and implications for primary care |
| Q30230101 | A research agenda for assessing the potential contribution of genomic medicine to tobacco control |
| Q35060258 | Achieving utility with family history: colorectal cancer risk |
| Q39934142 | Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany |
| Q48561345 | Adjunct prenatal testing: patient decisions regarding ethnic carrier screening and fluorescence in situ hybridization |
| Q39476447 | An alternative view on the task of prognosis |
| Q39829779 | Antenatal testing and the subsequent birth of a child with Down syndrome: a phenomenological study of parents’ experiences |
| Q48437277 | Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study |
| Q40533991 | Assessment of genetic testing and related counseling services: current research and future directions |
| Q37402720 | Beliefs about heritability of cancer and health information seeking and preventive behaviors |
| Q35113139 | Bioethical theory and practice in genetic screening for type 1 diabetes |
| Q40010271 | Choosing not to choose: reproductive responses of parents of children with genetic conditions or impairments |
| Q37029649 | Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease |
| Q35582618 | Current perceptions of cardiovascular gene therapy. |
| Q93486357 | Des directives sur le dépistage génétique des enfants en santé |
| Q30538206 | Development and validation of a brief screening instrument for psychosocial risk associated with genetic testing: a pan-Canadian cohort study |
| Q80801043 | Distress and family functioning in oncogenetic counselling for hereditary and familial breast and/or ovarian cancers |
| Q73293986 | Effects of spouses on distress experienced by BRCA1 mutation carriers over time |
| Q34135724 | Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions |
| Q37777161 | Ethical considerations in choosing a model for population‐based cystic fibrosis carrier screening |
| Q40601561 | Ethical dilemmas in testing for late onset conditions: reactions to testing and perceived impact on other family members |
| Q35985180 | Ethics and neuropsychiatric genetics: a review of major issues |
| Q37031206 | Exploring dispositional tendencies to seek online information about direct-to-consumer genetic testing |
| Q34401651 | Exploring psychological responses to genetic testing for Lynch Syndrome within the family context |
| Q48336389 | Genetic counselling protocols for hereditary non‐polyposis colorectal cancer: a survey of UK regional genetics centres |
| Q44734022 | Genetic screening for susceptibility to depression: can we and should we? |
| Q35438487 | Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience |
| Q33789382 | Genetic testing and public policy |
| Q34109245 | Genetic testing for inherited breast and ovarian cancer syndromes: important concepts for the primary care physician |
| Q34743510 | Genetic testing for lung cancer risk: if physicians can do it, should they? |
| Q51996073 | Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease. |
| Q41982192 | Genetics consortiums can offer views facilitating best practice in Alzheimer's disease |
| Q28383584 | Genetics through a primary care lens |
| Q38457046 | Genomics--the perfect information-seeking research problem |
| Q82247564 | Guidelines for genetic testing of healthy children |
| Q36790111 | Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study |
| Q33541104 | Individual differences in posttraumatic distress: problems with the DSM-IV model |
| Q24186890 | Interventions for improving understanding and minimising the psychological impact of screening |
| Q24243409 | Interventions for improving understanding and minimising the psychological impact of screening |
| Q24250122 | Interventions for improving understanding and minimising the psychological impact of screening |
| Q45169426 | Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain |
| Q21203008 | Malignant hyperthermia |
| Q35446354 | Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review. |
| Q35219030 | Modelling decisions to undergo genetic testing for susceptibility to common health conditions: an ancillary study of the Multiplex Initiative |
| Q35430126 | Newborn screening: new developments, new dilemmas. |
| Q40440384 | Nurses' views of longitudinal genetic screening of and research on children |
| Q46299284 | Parental attitudes and beliefs regarding the genetic testing of children |
| Q81158583 | Patients' knowledge of cystic fibrosis: genetic determinism and implications for treatment |
| Q35437777 | Predictive genetic testing in children and adults: a study of emotional impact |
| Q42679310 | Predictive genetic testing in young people for adult-onset conditions: where is the empirical evidence? |
| Q95797255 | Prenatal diagnosis on fetal cells from maternal blood: approaches and perspectives |
| Q36767678 | Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological consequences for women who undergo screening |
| Q36186801 | Prenatal screening, ethics and Down's syndrome: a literature review |
| Q33255375 | Prevalence of the use of cancer related self-tests by members of the public: a community survey |
| Q33246170 | Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they w |
| Q33338671 | Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they we |
| Q81886564 | Psycho-social counselling in predictive genetic testing for cancer: the association between number of supportive sessions and client characteristics as assessed by psycho-social workers |
| Q36456023 | Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I. |
| Q40562181 | Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. |
| Q48412678 | Psychological follow-up of presymptomatic genetic testing for spinocerebellar ataxia type 2 (SCA2) in Cuba. |
| Q33780621 | Psychological impact of predicting individuals' risks of illness: a systematic review. |
| Q61625933 | Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history |
| Q50762334 | Psychosocial consequences of genetic counseling: a population-based follow-up study. |
| Q57572367 | Research and Practice Opportunities at the Intersection of Health Education, Health Behavior, and Genomics |
| Q34451971 | Research issues in genetic testing of adolescents for obesity |
| Q57178162 | Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies |
| Q45885963 | Social cognitive predictors of intention to test for variant Creutzfeldt-Jakob disease in those affected by haemophilia and other clotting disorders |
| Q40089202 | The beliefs, and reported and intended behaviors of unaffected men in response to their family history of prostate cancer |
| Q37055319 | The genetics of nicotine addiction liability: ethical and social policy implications. |
| Q28201220 | The genetics of tobacco use: methods, findings and policy implications |
| Q45874493 | The genomic revolution: is the real risk under-investment rather than bankrupt health care systems? |
| Q41862235 | The human genome project: a false dawn?. Interview by Judy Jones |
| Q33789302 | The new genetics. Implications for clinical services in Britain and the United States |
| Q40107383 | The prediction of disease risk in genomic medicine |
| Q50949525 | The psychological impact of genetic testing on parents. |
| Q37157925 | The psychological impact of testing for thrombophilia: a systematic review |
| Q37321708 | The relative importance of undesirable truths |
| Q57572364 | The role of cognitive appraisal and worry in BRCA1/2 testing decisions among a clinic population |
| Q42757935 | Title did not reflect author's views |
| Q40602800 | To test or not to test: interest in genetic testing for Alzheimer's disease among middle-aged adults |
| Q37235119 | Understanding the impact of genetic testing for inherited retinal dystrophy. |
| Q73373395 | What is a genetic test, and why does it matter? |
| Q40494480 | Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial |
| Q52896295 | Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. |
| Q37385214 | Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study |
| Q37690501 | Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease |
| Q57923386 | ‘Medicine’s Next Goldmine?’ The Implications of New Genetic Health Technologies for the Health Service |
Search more.